查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1536674

失智症治療市場，按適應症、按藥物類別、按配銷通路、按國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Dementia Treatment Market, By Indication, By Drug Class, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年失智症治療市場規模為177.9021億美元，2024年至2032年複合年成長率為7.80%。

失智症治療市場-市場動態

失智症盛行率的上升和研發投資的增加預計將推動市場需求

受失智症影響的人數正在增加，尤其是老年人，這刺激了對有效治療和護理解決方案的需求。對失智症症狀的更高認知和改進的診斷工具有助於更早發現和治療，從而促進市場成長。此外，政府和醫療保健組織的支持，包括為研發和公共衛生活動提供資金，有助於推動創新和獲得治療。因此，隨著失智症盛行率的增加，對支持性照護服務的需求不斷成長，包括家庭照護、長期照護設施和照護者支持，從而推動市場成長。

數位健康解決方案、遠距醫療和個人化醫療等醫療技術的進步正在增強治療選擇並改善患者管理。此外，製藥公司、生技公司和創投家對失智症研究和藥物開發的大量投資也有助於市場的擴張。新藥物和治療方法的推出，特別是那些獲得監管部門批准的藥物和治療方法，透過擴大治療失智症的可用選擇，有助於市場成長。

失智症治療市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 7.80% 左右的複合年成長率成長

根據適應症細分，由於阿茲海默症的盛行率增加，預計阿茲海默症 (AD) 失智症細分市場將在 2023 年顯示最大的市場佔有率。

從藥品類別細分來看，由於加蘭他敏、多奈哌齊等處方率較高，膽鹼酯酶抑制劑細分市場將成為 2023 年的主導藥品類別。

根據配銷通路細分，由於醫院治療的需求量很大，醫院藥房部門將在 2023 年成為領先的配銷通路。

從地區來看，由於擁有頂級製藥公司和先進的醫療設施，北美將成為 2023 年的主要收入來源。

失智症治療市場-細分分析：

全球失智症治療市場根據適應症、藥物類別、配銷通路和地區進行細分。

根據適應症，市場分為六類：阿茲海默症失智症、血管性失智症、路易氏體失智症、額顳葉失智症（FTD）、巴金森氏症失智症等。阿茲海默症癡呆細分市場佔據主導地位。隨著阿茲海默症新治療藥物的批准不斷增加，促進了細分市場的成長。

根據藥物類別，市場分為五類：膽鹼酯酶抑制劑、NMDA 受體拮抗劑、MAO 抑制劑、組合藥物等。預計組合藥物領域在預測期內將以最高速度成長。

根據分銷管道，市場分為三類：醫院藥房、零售藥房和網路藥房。醫院藥房領域在市場中佔據主導地位，預計在預測期內將保持其較高的主導地位。隨著醫療保健數位化的快速發展，預計線上藥局將在預測期內以最快的速度成長。

失智症治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美在失智症治療市場上佔據主導地位。由於人口老化，患病率較高。在美國，近 650 萬 65 歲及以上的人患有阿茲海默症。由於先進的醫療基礎設施、高額醫療支出以及強勁的研發活動，北美在全球市場中佔有重要佔有率。歐洲是失智症治療市場的關鍵市場，在研究和醫療保健服務方面投資巨大。

失智症治療市場-競爭格局：

失智症治療市場競爭激烈，有許多公司參與開發和新型藥物療法。市場參與者非常重視阿茲海默症的研究和創新治療方法。公司擴大投資於個人化醫療方法，以根據患者的個人情況量身定做治療方案。與學術機構和其他公司的策略聯盟致力於增強研究能力並加快藥物開發。

最新進展：

2024年1月，衛材株式會社和百健（Biogen）公司核准Leqembi用於治療AD失智症引起的輕度認知障礙。

2023年5月，禮來公司表示，一項3期臨床研究的積極結果表明，donanemab顯著減緩了阿茲海默症的認知和功能衰退。

目錄

第1章：失智症治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 失智症治療市場片段（按適應症）
    • 按藥物類別分類的失智症治療市場片段
    • 按配銷通路分類的失智症治療市場片段
    • 按國家/地區分類的失智症治療市場片段
    • 按地區分類的失智症治療市場片段
  • 競爭洞察

第 3 章：失智症治療主要市場趨勢

  • 失智症治療市場促進因素
    • 市場促進因素的影響分析
  • 失智症治療市場限制
    • 市場限制影響分析
  • 失智症治療市場機會
  • 失智症治療市場未來趨勢

第 4 章：失智症治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：失智症治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：失智症治療市場格局

  • 2023 年失智症治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：失智症治療市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 阿茲海默症 癡呆
    • 血管性失智症
    • 路易氏體失智症
    • 額顳葉失智症 (FTD)
    • 帕金森氏症癡呆
    • 其他

第 8 章：失智症治療市場 - 按藥物類別

  • 概述
    • 按藥物類別分類的細分市場佔有率分析
    • 膽鹼酯酶抑制劑
    • NMDA 受體拮抗劑
    • MAO抑制劑
    • 複方藥物
    • 其他

第 9 章：失智症治療市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥房
    • 網路藥房

第 10 章：失智症治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美失智症治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按藥物類別）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲失智症治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按藥物類別）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區失智症治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模和預測（按藥物類別）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲失智症治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模與預測（按藥物類別）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲失智症治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按藥物類別）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 失智症治療產業

  • 競爭儀表板
  • 公司簡介
    • Eli Lilly and Company
    • Biogen Inc.
    • Roche Holding AG
    • Novartis International AG
    • Johnson & Johnson
    • AstraZeneca PLC
    • Amylyx Pharmaceuticals
    • Cassava Sciences, Inc.
    • Lundbeck A/S
    • Otsuka Pharmaceutical Co., Ltd.
    • Sanofi SA
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Takeda Pharmaceutical Company Limited
    • Eisai Co., Ltd.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3523

REPORT HIGHLIGHT

Dementia Treatment Market size was valued at USD 17,790.21 Million in 2023, expanding at a CAGR of 7.80% from 2024 to 2032.

Dementia treatment focuses on managing symptoms, improving quality of life, and slowing the progression of the disease. Dementia treatment plans are often tailored to the individual and may require adjustments over time as the disease progresses.

Dementia Treatment Market- Market Dynamics

Growing prevalence of dementia and increased investment in research & development are expected to propel market demand

The number of individuals affected by dementia is increasing especially among older adults, which fuels demand for effective treatments and care solutions. Greater awareness of dementia symptoms and improved diagnostic tools lead to earlier detection and treatment, contributing to market growth. Further, support from governments and healthcare organizations, including funding for research and development and public health campaigns, helps drive innovation and access to treatments. Thus, As the prevalence of dementia increases, there is a growing need for supportive care services, including home care, long-term care facilities, and caregiver support, driving market growth.

Advances in medical technology, such as digital health solutions, telemedicine, and personalized medicine, are enhancing treatment options and improving patient management. Additionally, Significant investments from pharmaceutical companies, biotech firms, and venture capitalists into dementia research and drug development contribute to the expansion of the market. The introduction of new drugs and treatments, particularly those receiving regulatory approval, contributes to market growth by expanding available options for managing dementia.

Dementia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2024-2032)

Based on Indication segmentation, the Alzheimer's disease (AD) dementia segment was predicted to show maximum market share in the year 2023, owing to the increased prevalence if Alzheimer's disease.

Based on Drug Class segmentation, the cholinesterase inhibitors segment was the leading drug class in 2023, due to high prescription rates of galantamine, donepezil, etc.

Based on Distribution Channel segmentation, the hospital pharmacy segment was the leading Distribution Channel in 2023, owing to the high need for hospital treatment.

On the basis of region, North America was the leading revenue generator in 2023, owing to presence of top pharmaceutical companies & advanced medical facilities.

Dementia Treatment Market- Segmentation Analysis:

The Global Dementia Treatment Market is segmented on the basis of Indication, Drug Class, Distribution Channel, and Region.

The market is divided into six categories based on Indication: Alzheimer's Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson's Disease Dementia, and others. The Alzheimer's Disease Dementia segment dominates the market. With the increasing approval of new therapeutics drugs in Alzheimer's boosting segment growth.

The market is divided into five categories based on Drug Class: cholinesterase inhibitors, NMDA receptor antagonists, MAO inhibitors, combination drugs, and others. The combination drugs segment is projected to grow at the highest rate over the forecast period.

The market is divided into three categories based on Distribution channels: hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominates the market and is expected to maintain its high dominance during the forecast period. Online pharmacy is anticipated to grow at the fastest rate during the forecast period with the rapid digitalization in healthcare.

Dementia Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Dementia Treatment market. High prevalence due to aging populations. In the U.S., nearly 6.5 million people aged 65 and older are living with Alzheimer's disease. North America holds a significant share of the global market due to advanced healthcare infrastructure, high healthcare expenditure, and robust research and development activities. Europe is a key market in the dementia treatment market with considerable investments in research and healthcare services.

Dementia Treatment Market- Competitive Landscape:

The dementia treatment market is highly competitive, with numerous companies involved in developing and novel drug therapies. Market players have a strong emphasis on Alzheimer's research and innovative treatments. Companies are increasingly investing in personalized medicine approaches to tailor treatments to individual patient profiles. Strategic alliances with academic institutions and other companies are focusing on enhancing research capabilities and speeding up drug development.

Recent Developments:

In January 2024, Eisai Co., Ltd. and Biogen got approval for Leqembi for the treatment of mild cognitive impairment due to AD dementia.

In May 2023, Eli Lilly stated the positive results of a phase-3 clinical study demonstrated that donanemab significantly slowed cognitive and functional decline in Alzheimer's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DEMENTIA TREATMENT MARKET KEY PLAYERS

  • Eli Lilly and Company
  • Biogen Inc.
  • Roche Holding AG
  • Novartis International AG
  • Johnson & Johnson
  • AstraZeneca PLC
  • Amylyx Pharmaceuticals
  • Cassava Sciences, Inc.
  • Lundbeck A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Eisai Co., Ltd.
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Alzheimer's Disease Dementia
  • Vascular Dementia
  • Lewy Body Dementia
  • Frontotemporal Dementia (FTD)
  • Parkinson Disease Dementia
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019-2032

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonist
  • MAO Inhibitors
  • Combination Drug
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019-2032

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

GLOBAL DEMENTIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Dementia Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Dementia Treatment Market Snippet by Indication
    • 2.1.2. Dementia Treatment Market Snippet by Drug Class
    • 2.1.3. Dementia Treatment Market Snippet by Distribution Channel
    • 2.1.4. Dementia Treatment Market Snippet by Country
    • 2.1.5. Dementia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Dementia Treatment Key Market Trends

  • 3.1. Dementia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Dementia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Dementia Treatment Market Opportunities
  • 3.4. Dementia Treatment Market Future Trends

4. Dementia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Dementia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Dementia Treatment Market Landscape

  • 6.1. Dementia Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Dementia Treatment Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 7.1.2. Alzheimer's Disease Dementia
    • 7.1.3. Vascular Dementia
    • 7.1.4. Lewy Body Dementia
    • 7.1.5. Frontotemporal Dementia (FTD)
    • 7.1.6. Parkinson Disease Dementia
    • 7.1.7. Others

8. Dementia Treatment Market - By Drug Class

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 8.1.2. Cholinesterase Inhibitors
    • 8.1.3. NMDA Receptor Antagonist
    • 8.1.4. MAO Inhibitors
    • 8.1.5. Combination Drug
    • 8.1.6. Others

9. Dementia Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy
    • 9.1.4. Online Pharmacy

10. Dementia Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Dementia Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Dementia Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Dementia Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Dementia Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Dementia Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Dementia Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eli Lilly and Company
    • 11.2.2. Biogen Inc.
    • 11.2.3. Roche Holding AG
    • 11.2.4. Novartis International AG
    • 11.2.5. Johnson & Johnson
    • 11.2.6. AstraZeneca PLC
    • 11.2.7. Amylyx Pharmaceuticals
    • 11.2.8. Cassava Sciences, Inc.
    • 11.2.9. Lundbeck A/S
    • 11.2.10. Otsuka Pharmaceutical Co., Ltd.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Pfizer Inc.
    • 11.2.13. Merck & Co., Inc.
    • 11.2.14. Takeda Pharmaceutical Company Limited
    • 11.2.15. Eisai Co., Ltd.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Dementia Treatment Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Dementia Treatment Market, by Indication 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Drug Class Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Dementia Treatment Market, by Drug Class 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Dementia Treatment Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Dementia Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • FIGURE Dementia Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Drug Class segment market share analysis, 2023 & 2032
  • FIGURE Drug Class segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2023 & 2032
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Dementia Treatment Market share and leading players, 2023
  • FIGURE Europe Dementia Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Dementia Treatment Market share and leading players, 2023
  • FIGURE Latin America Dementia Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Dementia Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Dementia Treatment Market share analysis by country, 2023
  • FIGURE Germany Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Dementia Treatment Market share analysis by country, 2023
  • FIGURE India Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Dementia Treatment Market share analysis by country, 2023
  • FIGURE Brazil Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Dementia Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)